Piper Sandler analyst Brent Bracelin says Veeva Systems' "strong" Q4 results help boost his confidence in the company's "upside levers" to growth over the next three years. Two top 10 customer wins outside of life sciences, a dozen early adopters of the new Safety product, and a seven-figure commercial win shows increasing product and customer diversification, Bracelin tells investors in a post-earnings research note. The analyst sees a favorable risk/reward with the stock down 20% from the 52-week highs. He keeps an Overweight rating on Veeva with a $188 price target.